Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D O Clegg

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Arthritis and Rheumatism|March 1, 1996
Early undifferentiated connective tissue disease. IV.Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baselineG S Alarcón, R F Willkens, J R Ward, et al.
The Journal of Rheumatology|May 6, 1999
Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTDH J Williams, G S Alarcon, R Joks, et al.
Arthritis and Rheumatism|November 1, 1996
HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid ArthritisJ D Reveille, G S Alarcón, S E Fowler, et al.
The Journal of Rheumatology|July 1, 1997
Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) TrialG B Bluhm, J T Sharp, B C Tilley, et al.
Annals of Internal Medicine|April 15, 1993
Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis)K J Bulpitt, P J Clements, P A Lachenbruch, et al.
American Journal of Human Genetics|March 20, 2001
A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseasesD Jawaheer, M F Seldin, C I Amos, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, E Mejias, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, M H Weisman, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, M H Weisman, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Arthritis and Rheumatism|March 1, 1996
Early undifferentiated connective tissue disease. IV.Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baselineG S Alarcón, R F Willkens, J R Ward, et al.
The Journal of Rheumatology|May 6, 1999
Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTDH J Williams, G S Alarcon, R Joks, et al.
Arthritis and Rheumatism|November 1, 1996
HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid ArthritisJ D Reveille, G S Alarcón, S E Fowler, et al.
The Journal of Rheumatology|July 1, 1997
Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) TrialG B Bluhm, J T Sharp, B C Tilley, et al.
Annals of Internal Medicine|April 15, 1993
Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis)K J Bulpitt, P J Clements, P A Lachenbruch, et al.
American Journal of Human Genetics|March 20, 2001
A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseasesD Jawaheer, M F Seldin, C I Amos, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, E Mejias, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, M H Weisman, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, M H Weisman, et al.
Pageof 9